Recent development of nonviral gene delivery systems with virus-like structures and mechanisms

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 71, Issue 3, 2009, Pages 475-483

  Itaka, Keiji ^a   Kataoka, Kazunori ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Biocompatibility; Gene therapy; Nanocarrier; Nonviral gene delivery; Polyplex micelle

Indexed keywords

ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; CHITOSAN; COLLAGEN SPONGE; FUGENE6; GAMMA INTERFERON; HEPARAN SULFATE; INTEGRIN; LIPOFECTIN; LIPOPLEX; MACROGOL; NUCLEASE S1; OSTEOCALCIN; PLASMID DNA; POLYETHYLENEIMINE; POLYMER; POLYPLEX; REAGENT; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; TRANSFERRIN; UNCLASSIFIED DRUG;

ALVEOLAR RIDGE; BACTERIOPHAGE; BIOCOMPATIBILITY; BONE REGENERATION; CELL DIFFERENTIATION; CELL STRAIN HEPG2; CONFOCAL LASER MICROSCOPY; CYTOTOXICITY; DNA PACKAGING; ENDOCYTOSIS; FREEZE DRYING; GENE EXPRESSION; GENE SILENCING; HOUSEKEEPING GENE; HUMAN; HUMAN RHINOVIRUS; IMMUNOGENICITY; IN VIVO GENE TRANSFER; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; LEUKEMIA; MICELLE; MOUSE; MYOFIBROBLAST; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; RAT; REVIEW; RNA INTERFERENCE; SEVERE COMBINED IMMUNODEFICIENCY; STELLATE CELL; TISSUE ENGINEERING; TRANSGENE; TUMOR SPHEROID; VIRUS ATTACHMENT; VIRUS LIKE AGENT; WOUND HEALING;

CATIONS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIPIDS; POLYMERS; TISSUE ENGINEERING; TRANSGENES;

EID: 60749111194     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.09.019     Document Type: Review

References (99)

1. Winn S.R., Hu Y., Sfeir C., and Hollinger J.O. Gene therapy approaches for modulating bone regeneration. Adv. Drug Deliv. Rev. 42 (2000) 121-138
2. Howell T.H., Fiorellini J., Jones A., Alder M., Nummikoski P., Lazaro M., Lilly L., and Cochran D. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int. J. Periodontics Restorative Dent.. 17 (1997) 124-139
3. Morishita R. Perspective in progress of cardiovascular gene therapy. J. Pharmacol. Sci. 95 (2004) 1-8
4. Evans C.H., Ghivizzani S.C., and Robbins P.D. The 2003 Nicolas Andry Award. Orthopaedic gene therapy. Clin. Orthop. Relat. Res. (2004) 316-329
5. Branski L.K., Pereira C.T., Herndon D.N., and Jeschke M.G. Gene therapy in wound healing: present status and future directions. Gene Ther. (2006)
6. Baltzer A.W., and Lieberman J.R. Regional gene therapy to enhance bone repair. Gene Ther. 11 (2004) 344-350
7. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 286 (1999) 2244-2245
8. Hollon T. Researchers and regulators reflect on first gene therapy death. Am. J. Ophthalmol. 129 (2000) 701
9. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee, Hum. Gene Ther. 13 (2002) 3-13.
10. Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., Gross F., Yvon E., Nusbaum P., Selz F., Hue C., Certain S., Casanova J.L., Bousso P., Deist F.L., and Fischer A. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288 (2000) 669-672
11. Fischer A., Hacein-Bey-Abina S., Lagresle C., Garrigue A., and Cavazana-Calvo M. Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome. Bull. Acad. Natl. Med. 189 (2005) 779-785 discussion 786-788
12. Another case of gene therapy-associated leukemia. Biotechnology Law Report 27 (2008) 11.
13. Marsh M., and Helenius A. Virus entry: open sesame. Cell 124 (2006) 729-740
14. Jiang W., Chang J., Jakana J., Weigele P., King J., and Chiu W. Structure of epsilon15 bacteriophage reveals genome organization and DNA packaging/injection apparatus. Nature 439 (2006) 612-616
15. Oliveira L., Alonso J.C., and Tavares P. A defined in vitro system for DNA packaging by the bacteriophage SPP1: insights into the headful packaging mechanism. J. Mol. Biol. 353 (2005) 529-539
16. Lander G.C., Tang L., Casjens S.R., Gilcrease E.B., Prevelige P., Poliakov A., Potter C.S., Carragher B., and Johnson J.E. The structure of an infectious P22 virion shows the signal for headful DNA packaging. Science 312 (2006) 1791-1795
17. Oupicky D., Konak C., Ulbrich K., Wolfert M.A., and Seymour L.W. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers. J. Control. Release 65 (2000) 149-171
18. De Smedt S.C., Demeester J., and Hennink W.E. Cationic polymer based gene delivery systems. Pharm. Res. 17 (2000) 113-126
19. Oupicky D., Konak C., and Ulbrich K. DNA complexes with block and graft copolymers of N-(2-hydroxypropyl)methacrylamide and 2-(trimethylammonio)ethyl methacrylate. J. Biomater. Sci. Polym. Ed. 10 (1999) 573-590
20. Goncalves C., Pichon C., Guerin B., and Midoux P. Intracellular processing and stability of DNA complexed with histidylated polylysine conjugates. J. Gene Med. 4 (2002) 271-281
21. Itaka K., Harada A., Yamasaki Y., Nakamura K., Kawaguchi H., and Kataoka K. In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J. Gene Med. 6 (2004) 76-84
22. Katayose S., and Kataoka K. Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(l-lysine) block copolymer. Bioconjug. Chem. 8 (1997) 702-707
23. Itaka K., Yamauchi K., Harada A., Nakamura K., Kawaguchi H., and Kataoka K. Polyion complex micelles from plasmid DNA and poly(ethylene glycol)-poly(l-lysine) block copolymer as serum-tolerable polyplex system: physicochemical properties of micelles relevant to gene transfection efficiency. Biomaterials 24 (2003) 4495-4506
24. Osada K., Yamasaki Y., Katayose S., and Kataoka K. A synthetic block copolymer regulates S1 nuclease fragmentation of supercoiled plasmid DNA. Angew. Chem. Int. Ed. Engl. 44 (2005) 3544-3548
25. Osada K., and Kataoka K. Drug and gene delivery based on supramolecular assembly of PEG-polypeptide hybrid block copolymers. Adv. Polym. Sci. 202 (2006) 113-153
26. Tsumoto K., Luckel F., and Yoshikawa K. Giant DNA molecules exhibit on/off switching of transcriptional activity through conformational transition. Biophys. Chem. 106 (2003) 23-29
27. Yoshikawa K. Field hypothesis on the self-regulation of gene expression. J. Biol. Phys. 28 (2002) 701-712
28. Allen T.M., Mehra T., Hansen C., and Chin Y.C. Stealth liposomes: an improved sustained release system for 1-beta-d-arabinofuranosylcytosine. Cancer Res. 52 (1992) 2431-2439
29. Blume G., and Cevc G. Liposomes for the sustained drug release in vivo. Biochim. Biophys. Acta 1029 (1990) 91-97
30. Allen T.M., Hansen C., Martin F., Redemann C., and Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066 (1991) 29-36
31. Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., and Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta 1128 (1992) 44-49
32. Ogris M., Walker G., Blessing T., Kircheis R., Wolschek M., and Wagner E. Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J. Control. Release 91 (2003) 173-181
33. Wolschek M.F., Thallinger C., Kursa M., Rossler V., Allen M., Lichtenberger C., Kircheis R., Lucas T., Willheim M., Reinisch W., Gangl A., Wagner E., and Jansen B. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology 36 (2002) 1106-1114
34. Kursa M., Walker G.F., Roessler V., Ogris M., Roedl W., Kircheis R., and Wagner E. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug. Chem. 14 (2003) 222-231
35. Ogris M., Brunner S., Schuller S., Kircheis R., and Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6 (1999) 595-605
36. Verbaan F.J., Oussoren C., Snel C.J., Crommelin D.J., Hennink W.E., and Storm G. Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice. J. Gene Med. 6 (2004) 64-75
37. Katayose S., and Kataoka K. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(l-lysine) block copolymer. J. Pharm. Sci. 87 (1998) 160-163
38. Kataoka K., Harada A., and Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 47 (2001) 113-131
39. Harada-Shiba M., Yamauchi K., Harada A., Takamisawa I., Shimokado K., and Kataoka K. Polyion complex micelles as vectors in gene therapy - pharmacokinetics and in vivo gene transfer. Gene Ther. 9 (2002) 407-414
40. Kanayama N., Fukushima S., Nishiyama N., Itaka K., Jang W.D., Miyata K., Yamasaki Y., Chung U.I., and Kataoka K. A PEG-based biocompatible block catiomer with high buffering capacity for the construction of polyplex micelles showing efficient gene transfer toward primary cells. Chem. Med. Chem. 1 (2006) 439-444
41. Walker G.F., Fella C., Pelisek J., Fahrmeir J., Boeckle S., Ogris M., and Wagner E. Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol. Ther. 11 (2005) 418-425
42. Miyata K., Kakizawa Y., Nishiyama N., Yamasaki Y., Watanabe T., Kohara M., and Kataoka K. Freeze-dried formulations for in vivo gene delivery of PEGylated polyplex micelles with disulfide crosslinked cores to the liver. J. Control. Release 109 (2005) 15-23
43. Itaka K., Ohba S., Miyata K., Kawaguchi H., Nakamura K., Takato T., Chung U.I., and Kataoka K. Bone regeneration by regulated in vivo gene transfer using biocompatible polyplex nanomicelles. Mol. Ther. 15 (2007) 1655-1662
44. Han M., Bae Y., Nishiyama N., Miyata K., Oba M., and Kataoka K. Transfection study using multicellular tumor spheroids for screening non-viral polymeric gene vectors with low cytotoxicity and high transfection efficiencies. J. Control. Release 121 (2007) 38-48
45. Sutherland R.M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240 (1988) 177-184
46. Ugolini S., Mondor I., and Sattentau Q.J. HIV-1 attachment: another look. Trends Microbiol. 7 (1999) 144-149
47. Vlasak M., Goesler I., and Blaas D. Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J. Virol. 79 (2005) 5963-5970
48. Wu G.Y., and Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262 (1987) 4429-4432
49. Wu G.Y., and Wu C.H. Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 263 (1988) 14621-41624
50. Wu G.Y., and Wu C.H. Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro. Biochemistry 27 (1988) 887-892
51. Midoux P., Mendes C., Legrand A., Raimond J., Mayer R., Monsigny M., and Roche A.C. Specific gene transfer mediated by lactosylated poly-l-lysine into hepatoma cells. Nucleic Acids Res. 21 (1993) 871-878
52. Erbacher P., Roche A.C., Monsigny M., and Midoux P. Glycosylated polylysine/DNA complexes: gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size. Bioconjug. Chem. 6 (1995) 401-410
53. Erbacher P., Bousser M.T., Raimond J., Monsigny M., Midoux P., and Roche A.C. Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. Hum. Gene Ther. 7 (1996) 721-729
54. Wagner E., Zenke M., Cotten M., Beug H., and Birnstiel M.L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. USA 87 (1990) 3410-3414
55. Wagner E., Cotten M., Foisner R., and Birnstiel M.L. Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proc. Natl. Acad. Sci. USA 88 (1991) 4255-4259
56. Wagner E., Cotten M., Mechtler K., Kirlappos H., and Birnstiel M.L. DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. Bioconjug. Chem. 2 (1991) 226-231
57. Mislick K.A., Baldeschwieler J.D., Kayyem J.F., and Meade T.J. Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery. Bioconjug. Chem. 6 (1995) 512-515
58. Leamon C.P., Weigl D., and Hendren R.W. Folate copolymer-mediated transfection of cultured cells. Bioconjug. Chem. 10 (1999) 947-957
59. Kim J.S., Kim B.I., Maruyama A., Akaike T., and Kim S.W. A new non-viral DNA delivery vector: the terplex system. J. Control. Release 53 (1998) 175-182
60. Furgeson D.Y., Chan W.S., Yockman J.W., and Kim S.W. Modified linear polyethylenimine-cholesterol conjugates for DNA complexation. Bioconjug. Chem. 14 (2003) 840-847
61. Erbacher P., Remy J.S., and Behr J.P. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. 6 (1999) 138-145
62. Fisher K.D., Ulbrich K., Subr V., Ward C.M., Mautner V., Blakey D., and Seymour L.W. A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Ther. 7 (2000) 1337-1343
63. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., Buchberger M., and Wagner E. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4 (1997) 409-418
64. Godbey W.T., Wu K.K., and Mikos A.G. Poly(ethylenimine) and its role in gene delivery. J. Control. Release 60 (1999) 149-160
65. Hashimoto M., Morimoto M., Saimoto H., Shigemasa Y., and Sato T. Lactosylated chitosan for DNA delivery into hepatocytes: the effect of lactosylation on the physicochemical properties and intracellular trafficking of pDNA/chitosan complexes. Bioconjug. Chem. 17 (2006) 309-316
66. von Gersdorff K., Sanders N.N., Vandenbroucke R., De Smedt S.C., Wagner E., and Ogris M. The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type. Mol Ther. 14 (2006) 745-753
67. Bartlett D.W., Su H., Hildebrandt I.J., Weber W.A., and Davis M.E. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc. Natl. Acad. Sci. USA 104 (2007) 15549-15554
68. Oba M., Fukushima S., Kanayama N., Aoyagi K., Nishiyama N., Koyama H., and Kataoka K. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins. Bioconjug. Chem. 18 (2007) 1415-1423
69. Kogure K., Moriguchi R., Sasaki K., Ueno M., Futaki S., and Harashima H. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J. Control. Release 98 (2004) 317-323
70. Kogure K., Akita H., and Harashima H. Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of Programmed Packaging. J. Control. Release 122 (2007) 246-251
71. Kogure K., Akita H., Yamada Y., and Harashima H. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. Adv. Drug Deliv. Rev. (2007)
72. Gansbacher B. Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT). J. Gene Med. 5 (2003) 261-262
73. Egermann M., Lill C.A., Griesbeck K., Evans C.H., Robbins P.D., Schneider E., and Baltzer A.W. Effect of BMP-2 gene transfer on bone healing in sheep. Gene Ther. 13 (2006) 1290-1299
74. Beutler B. Inferences, questions and possibilities in toll-like receptor signalling. Nature 430 (2004) 257-263
75. Dow S.W., Fradkin L.G., Liggitt D.H., Willson A.P., Heath T.D., and Potter T.A. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J. Immunol. 163 (1999) 1552-1561
76. Tousignant J.D., Gates A.L., Ingram L.A., Johnson C.L., Nietupski J.B., Cheng S.H., Eastman S.J., and Scheule R.K. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: plasmid DNA complexes in mice. Hum. Gene Ther. 11 (2000) 2493-2513
77. Gautam A., Densmore C.L., and Waldrep J.C. Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther. 8 (2001) 254-257
78. Sakurai F., Terada T., Yasuda K., Yamashita F., Takakura Y., and Hashida M. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes. Gene Ther. 9 (2002) 1120-1126
79. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
80. Yew N.S., Zhao H., Przybylska M., Wu I.H., Tousignant J.D., Scheule R.K., and Cheng S.H. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol. Ther. 5 (2002) 731-738
81. Zhao H., Hemmi H., Akira S., Cheng S.H., Scheule R.K., and Yew N.S. Contribution of Toll-like receptor 9 signaling to the acute inflammatory response to nonviral vectors. Mol. Ther. 9 (2004) 241-248
82. Nomura T., Yasuda K., Yamada T., Okamoto S., Mahato R.I., Watanabe Y., Takakura Y., and Hashida M. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice. Gene Ther. 6 (1999) 121-129
83. Whitmore M., Li S., and Huang L. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther. 6 (1999) 1867-11875
84. Kabanov A.V., Batrakova E.V., Sriadibhatla S., Yang Z., Kelly D.L., and Alakov V.Y. Polymer genomics: shifting the gene and drug delivery paradigms. J. Control. Release 101 (2005) 259-271
85. Omidi Y., Hollins A.J., Benboubetra M., Drayton R., Benter I.F., and Akhtar S. Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells. J. Drug Target 11 (2003) 311-323
86. Omidi Y., Hollins A.J., Drayton R.M., and Akhtar S. Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type. J. Drug Target 13 (2005) 431-443
87. Hollins A.J., Omidi Y., Benter I.F., and Akhtar S. Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity. J. Drug Target 15 (2007) 83-88
88. Masago K., Itaka K., Nishiyama N., Chung U.I., and Kataoka K. Gene delivery with biocompatible cationic polymer: pharmacogenomic analysis on cell bioactivity. Biomaterials 28 (2007) 5169-5175
89. Hellgren I., Drvota V., Pieper R., Enoksson S., Blomberg P., Islam K.B., and Sylven C. Highly efficient cell-mediated gene transfer using non-viral vectors and FuGene6: in vitro and in vivo studies. Cell. Mol. Life Sci. 57 (2000) 1326-1333
90. Weiskirchen R., Kneifel J., Weiskirchen S., van de Leur E., Kunz D., and Gressner A.M. Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts. BMC Cell Biol. 1 (2000) 4
91. Lee M.J., Cho S.S., You J.R., Lee Y., Kang B.D., Choi J.S., Park J.W., Suh Y.L., Kim J.A., Kim D.K., and Park J.S. Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model. Gene Ther. 9 (2002) 859-866
92. Elmadbouh I., Rossignol P., Meilhac O., Vranckx R., Pichon C., Pouzet B., Midoux P., and Michel J.B. Optimization of in vitro vascular cell transfection with non-viral vectors for in vivo applications. J. Gene Med. 6 (2004) 1112-1124
93. Tinsley R.B., Faijerson J., and Eriksson P.S. Efficient non-viral transfection of adult neural stem/progenitor cells, without affecting viability, proliferation or differentiation. J. Gene Med. 8 (2006) 72-81
94. Hunter A.C. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv. Drug Deliv. Rev. 58 (2006) 1523-1531
95. Nel A., Xia T., Madler L., and Li N. Toxic potential of materials at the nanolevel. Science 311 (2006) 622-627
96. Nishiyama N., Iriyama A., Jang W.D., Miyata K., Itaka K., Inoue Y., Takahashi H., Yanagi Y., Tamaki Y., Koyama H., and Kataoka K. Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer. Nat. Mater. 54 (2005) 934-941
97. Liang H.D., Lu Q.L., Xue S.A., Halliwell M., Kodama T., Cosgrove D.O., Stauss H.J., Partridge T.A., and Blomley M.J. Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med. Biol. 30 (2004) 1523-1529
98. Liu F., Song Y., and Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6 (1999) 1258-1266
99. Zhang G., Budker V., and Wolff J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10 (1999) 1735-1737